Treatment choices in thyroid cancer
Treatment choices in thyroid cancer
Clinical advances in treating colorectal cancer
Impact of licensing and reimbursement discrepancies on cancer care in Europe and Canada
ABP 980, a biosimilar antibody for trastuzumab
New strategies in melanoma care
Real-world productivity of advanced gastric cancer patients
Abemaciclib for advanced breast cancer
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer
CheckMate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
Chemotherapy then surgery no better than concomitant chemoradiation for advanced cervical cancer
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer